Regulatory Compliance Response: Astec LifeSciences Limited
Date and Nature of Query
- Date of Communication: 11th November, 2026
- Exchange Query Reference: NSE Notice Ref. No. NSE/CM/Surveillance/17777 dated 9th November, 2026
- Nature of Query: Significant increase in the volume of security across exchanges in the recent past
Company's Clarification on Trading Volume
Astec LifeSciences Limited confirmed that as a listed company, it is conscious of its responsibility to disseminate information that could impact the company's share price. The company stated it has been promptly disseminating events or information required to be disclosed pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company specifically confirmed that there are no developments that have taken place requiring mandatory disclosure under:
- The Listing Regulations
- The Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations)
Regulatory Compliance Reference
The company affirmed its full compliance with disclosure obligations under:
- SEBI Listing Obligations and Disclosure Requirements Regulations, 2015 (Regulation 30 specifically mentioned)
- SEBI Prohibition of Insider Trading Regulations, 2015
The company committed to continuing full compliance with these regulations and making appropriate disclosures as mandated when required.